Literature DB >> 23115100

Potassium-induced conversion of ventricular fibrillation after aortic declamping.

Sven M Almdahl1, Jens Damstuen, Magne Eide, Per Mølstad, Per Halvorsen, Terje Veel.   

Abstract

OBJECTIVES: The anti-fibrillatory effect of potassium is well recognized from experimental models. There have, however, been very few clinical reports on the use of potassium to convert ventricular fibrillation (VF) after cardioplegic arrest.
METHODS: In total, 8465 adult patients undergoing cardiac operations on cardiopulmonary bypass (CPB) and with cold antegrade crystalloid cardioplegic arrest were consecutively enrolled in a database. Patients with VF after removal of the aortic clamp were given 20 mmol potassium, and if needed an extra 10 mmol, in the perfusion line and the conversion rate was registered. Preoperative and intraoperative factors possibly related to the occurrence of post-ischaemic VF were assessed.
RESULTS: Of these, 1721 (20%) patients had VF and 1366 of these (79%) were successfully treated with potassium infusion. Only 355 (21%) patients (4% of all operations) had direct-current countershock. The need for pacing was lower in the treatment group compared with the non-treatment group (P <0.001). Multivariate analysis revealed as the main findings that age, gender, amount of cardioplegia related to body mass index (BMI), and blood transfusion during the time of CPB had a highly significant (P <0.001) impact on reducing the rate of post-arrest VF. Somewhat contrary to expectation, left ventricular hypertrophy (LVH) was not a significant factor (P = 0.32) for post-arrest VF. No conversion by potassium was significant for age (P <0.001), gender (P <0.001) and LVH (P <0.001), but not for blood transfusion during CPB (P = 0.38) and for the ratio of cardioplegia-BMI (P = 0.26).
CONCLUSIONS: The results from this register study demonstrate that potassium infusion is an effective and convenient first-hand measure to convert post declamping VF on CPB.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23115100      PMCID: PMC3548536          DOI: 10.1093/icvts/ivs455

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  25 in total

Review 1.  Myocardial protection: an overview.

Authors:  J Vinten-Johansen; V H Thourani
Journal:  J Extra Corpor Technol       Date:  2000-03

2.  Cold blood versus cold crystalloid cardioplegia: a prospective randomised study of 345 aortic valve patients.

Authors:  Eivind Øvrum; Geir Tangen; Stein Tølløfsrud; Rolf Øystese; Mari-Anne L Ringdal; Reidar Istad
Journal:  Eur J Cardiothorac Surg       Date:  2010-05-07       Impact factor: 4.191

3.  Controlled aortic root perfusion: a novel method to treat refractory ventricular arrhythmias after aortic valve replacement.

Authors:  Shrinivas Vitthal Gadhinglajkar; Rupa Sreedhar; Praveen K Varma
Journal:  J Cardiothorac Vasc Anesth       Date:  2004-04       Impact factor: 2.628

4.  Invited commentary.

Authors:  John Conte
Journal:  Ann Thorac Surg       Date:  2010-06       Impact factor: 4.330

5.  Secondary cross-clamping and blood cardioplegia for refractory ventricular fibrillation.

Authors:  Rıza Turkoz; Emre Ozker; Ayda Turkoz
Journal:  Ann Thorac Surg       Date:  2011-07       Impact factor: 4.330

6.  Potassium-induced cardiac resetting technique for persistent ventricular tachycardia and fibrillation after aortic declamping.

Authors:  Go Watanabe; Noriyoshi Yashiki; Shigeyuki Tomita; Shojiro Yamaguchi
Journal:  Ann Thorac Surg       Date:  2011-02       Impact factor: 4.330

7.  Systemic hyperkalemia and mild hypothermia for valve surgery in patients with patent internal mammary artery graft.

Authors:  Tomoyuki Fujita; Junjiro Kobayashi; Hiroyuki Nakajima; Koichi Toda
Journal:  Interact Cardiovasc Thorac Surg       Date:  2010-04-12

8.  The influence of gender on the outcome of coronary artery bypass surgery.

Authors:  D Abramov; M G Tamariz; J Y Sever; G T Christakis; G Bhatnagar; A L Heenan; B S Goldman; S E Fremes
Journal:  Ann Thorac Surg       Date:  2000-09       Impact factor: 4.330

9.  Effects of [K(+)](o) on electrical restitution and activation dynamics during ventricular fibrillation.

Authors:  M L Koller; M L Riccio; R F Gilmour
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

10.  Biochemical termination of sustained fibrillation occurring after artificially induced ischemic arrest.

Authors:  F Robicsek
Journal:  J Thorac Cardiovasc Surg       Date:  1984-01       Impact factor: 5.209

View more
  3 in total

1.  Beneficial Effects of Adjusted Perfusion and Defibrillation Strategies on Rhythm Control within Controlled Automated Reperfusion of the Whole Body (CARL) for Refractory Out-of-Hospital Cardiac Arrest.

Authors:  Sam Joé Brixius; Jan-Steffen Pooth; Jörg Haberstroh; Domagoj Damjanovic; Christian Scherer; Philipp Greiner; Christoph Benk; Friedhelm Beyersdorf; Georg Trummer
Journal:  J Clin Med       Date:  2022-04-11       Impact factor: 4.964

2.  Energy conserving chemical defibrillation of ventricular fibrillation: A randomized two phase controlled blinded trial.

Authors:  Keith A Marill; David D Salcido; Matthew L Sundermann; Allison C Koller; James J Menegazzi
Journal:  Resuscitation       Date:  2016-03-31       Impact factor: 5.262

3.  Cardioplegic arrest as pharmacological defibrillation; A novel approach for refractory ventricular fibrillation.

Authors:  Vivek Chowdhry
Journal:  Ann Card Anaesth       Date:  2020 Oct-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.